Shuting Lai

Title: Innovations of Inventor Shuting Lai

Introduction

Shuting Lai is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, his work focuses on enhancing the efficacy and stability of drug delivery systems.

Latest Patents

One of Shuting Lai's latest patents is the "Preparation method of sustained-release microparticles." This invention outlines a process that maintains normal or low temperatures during the preparation of sustained-release microparticles. This method is particularly beneficial for high-temperature-sensitive drugs, such as proteins, nucleic acids, and peptides. The bioactivity of the active substances is preserved throughout the process, resulting in microparticles that exhibit an excellent sustained-release effect. This innovation addresses the shortcomings of conventional methods, ensuring a stable drug concentration during release and achieving higher drug loading and encapsulation rates.

Another significant patent is the "Targeted hydrophobic anti-tumor drug nanoformulation and preparation method thereof." This invention involves a targeted formulation that combines a hydrophobic anti-tumor drug with a carrier in a specific mass ratio. The carrier consists of albumin and a hyaluronic acid-albumin conjugate, which is prepared in a defined molar ratio. The preparation method includes several steps, such as formulating the carrier and drug solutions. The resulting nanoformulation demonstrates even particle size distribution, good dispersibility, and stability, making it a promising candidate for effective anti-tumor therapies.

Career Highlights

Shuting Lai is currently associated with Ac Pharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to improve drug delivery systems and enhance therapeutic outcomes.

Collaborations

Shuting Lai collaborates with talented individuals in his field, including Feng Liu and Yang Zheng. Their combined expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Shuting Lai's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving drug delivery systems. His work not only addresses critical challenges in the industry but also paves the way for future advancements in targeted therapies.